MP0533

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameMP0533

Drug Alias NameMP0533

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Tetraspecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-CD3Anti-Myeloid cell surface antigen CD33Anti-CD70 +[4]

TargetsT cell surface glycoprotein CD3Myeloid cell surface antigen CD33CD70 antigen +[4]

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesNetherlandsSwitzerland +[5]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesMolecular Partners Ag

China Registration ClassN/A

Develop Information

Active CompaniesMolecular Partners Ag

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A